(Received for publication September 28, 1991) Eight antifungal compounds were identified from the fermentation of Actinomadura sp. SCC 1778. This culture produces four homologous compounds (C22H42N2O5~C25H48N2O5) containing the sugar, mycosamine, and four homologous compounds (C22H42N2O5~C25H48N2O5) containing the sugar, 3,6-dideoxy-3-amino-L-talopyranose.
Five of the compounds identified were novel macrolactams.All these compoundsexhibit antifungal activity against Candida spp. with geometric mean MICs ranging from approximately 1.0/tg/ml for the higher homologs to 30^g/ml for the lower homologs.
The evaluation of fermentation products of rare actinomycetes led to the discovery of a complex of antifungal antibiotics active in an assay that detects inhibitors of fungal cell envelope integrity1*. The producing culture, was identified as a member of the genus Actinomadura, but differed from Actinomadura sp., the macrolactam producers described elsewhere2~4). The complex, Sch 38510, was isolated from the fermentation broth of culture SCC 1778 by solvent extraction and consisted of eight macrolactam components. Five macrolactams are reported for the first time, three compounds, Sch 38516, Sch 38518 and Sch 39185, have been previously described3A). This paper describes the isolation, characterization, structures and biological activity of this novel series of macrolactams. Taxonomy The producing culture, SCC1778, was isolated from a soil sample collected in Uruguay. Soil was suspended in distilled water at a concentration of 1.0 g per 10ml, serially diluted and 0.1 ml streaked onto the surface of plating mediumcontaining soluble starch, 0.1%; yeast extract, 0.1%; agar, 1.5%; and neomycin, 1 /tg/ml. Discreet colonies developed after 14~21 days at 28~30°C.
The culture is a Gram-positive, filamentous organism forming well developed, moderately branching, non-fragmenting substrate hyphae approximately 0.4 to 0.8 /an in diameter. Aerial hyphae are formed on some meida and when presented are approximately 0.6 to 1.0/an in diameter and fragment into chains of 6 to 23 spores. Spores are round to ovoid, smooth walled and approximately 1.1 to 1.5/an in diameter. Spore chains are arranged in tightly appressed spirals, forming pseudosporangia 1.5 to 5. The complete taxonomic analysis will be published elsewhere.
Fermentation The initial stage inoculum for the fermentation of this culture was prepared by transferring 2.5 ml of a frozen whole broth (10% glycerol in seed medium stored at 30°C) to 50ml of seed medium in a 250-ml Erlenmeyer flask. The medium consisted of (w/v): beef extract 0.3%, Tryptone 0.5%, yeast extract 0.5%, Cerelose 0.1%, potato starch 2.4% and CaCO3 0.2%. The pH of the medium was adjusted to 7.0 prior to sterilization with 0.1 n NaOH.The flasks were incubated at 30°C for 48hours on a rotary shaker with a 5-cm throw at 300rpm. For the second stage germination, 2-liter flasks containing 500ml of the same mediumwere inoculated with 25 ml of the first stage seed. The conditions for incubation were the same as previously described. Production in flasks was initiated by transferring 25ml of the second stage germination into 2-liter flasks containing 500 ml of production medium which consisted of (w/v): cotton seed flower 1.0%, peptone 0.1%, Cerelose 0.5%, corn steep liquor 0.5%, arabinose 0.5%, MgCl2 -6H2O 0.5%, ZnSO4-7H2O 0.005%, FeSO4-7H2O 0.0014% and antifoam 0.1%. The pH of the solution was adjusted to 7.0 with 0.1 n NaOHprior to the addition of mineral salts. The fermentation was run for 90hours at 30°C on a 300rpm rotary shaker. Production and isolation of the antibiotic complex was monitored by agar diffusion against Candida albicans.
The second stage germination was also used to inoculate 100liters of production medium (5% transfer) run in a 150-liter fermenter (Fermatron, New Brunswick Scientific, Edison, NJ). The fermentation was carried out at 30°C with aeration of 4liters/minute and agitation of 400 rpm. The pH and dissolved oxygen levels were continuously monitored without adjustment and microbial growth was determined by packed cell volume at various intervals. Production and isolation of the antibiotic complex was followed as described above. A typical time course for the fermentation is shown in Fig. 1 . Antibiotic production was measured by welling the broth against Candida albicans, approaching a maximumafter 3 days before reaching a plateau. 
Isolation
The filtered broth (4liters) from shake flask experiments was extracted with ethyl acetate, and the antifungal complex precipitated from ether-hexane (6:4). The enriched fraction was chromatographed on Sephadex LH-20 eluting with MeOH.Although TLC, followed by bioautography against Candida albicans, of the combined active fractions indicated one spot (Whatman, silica gel LK6F, CHC13-MeOH-petroleum ether-H2O, 3 : 3 : 1 : 1, lower phase, Rf0.3), liquid-liquid chromatography using droplet counter current chromatography (DCCC), resolved the mixture into 4 closely related components. A model DCCC-A-300 (Tokyo Rikakikai Co., Tokyo, Japan) instrument with 300 glass columns (2mm (i.d.) x 40 cm) was used with a CHC13-MeOH-H2O (7:
Large scale (300liters) purification from culture broth and HPLC analysis8) revealed a much A: MCI CHP20P gel, elute gradient H2O pH 2.5 to (30~90%) MeOH. B: Droplet counter current chromatography, CHC13 -CH3OH-H2O (7 : 13 : 8, ascending). more complex mixture, 1~8, necessitating a modification of the original isolation scheme, described above. Thus as illustrated in Scheme1, after ethyl acetate extraction and precipitation with ether, the crude complex was subjected to chromatography on a column of MCICHP20Pgel (5 x 60cm) and eluted with a linear gradient consisting of dilute acetic acid (pH 2.5) to 100% MeOH.Components 1~3 are the major components from this broth and were chosen for further study. Components 4, 7 and 8 have been reported elsewhere2~4). Components 5 and 6 were isolated as mixtures and were only characterized further by HPLC8) and MS.
Experimental
All FABmass spectra were obtained by using a Finnigan MAT-312mass spectrometer in a glycerolthioglycerol matrix. NMR,spectra were measured on a Varian XL-200 instrument operating at 200 and 50MHz for *H and 13C NMR, respectively. *H and 13C NMRspectra recorded relative to TMSas an internal standard. (Table 1) . Fragmentation of the protonated molecular ion for each compoundproceeded in the same manner. Loss of the amino sugar from the molecule was observed, indicated by the ion fragments observed at m/z 164 and 146. Upon cleavage of this sugar, the corresponding ion fragment for the aglycone portion for 1 to 4 was observed differing by 14 mass units, indicating an homologous series in the macrolactam ring. In the FABmass spectrum, we observed protonated molecular ions (M + H)+ at m/z 415 and m/z 429 for 5 and 6, respectively. Since the HPLCretention times differentiated them from 1 and 2, they are assigned as the corresponding isomers8).
Physico-chemical Properties and Structures
lH NMRspectra of 1, 2 and 3 revealed a complex pattern. Multiplet signals in the region S 1~1.2 pertaining to methyl groups were observed. The complex of signals at S 2.8~3.8 and 5 4.7~5.0 were not further resolved (full details and the *H NMRanalysis of Sch 38518 have been reported4)). The 13C NMR spectra were much more informative and the data are presented in Table 2 . The chemical shift assignments for 1~3 are based on fully decoupled and APT spectra. These data are compared to the data reported for Sch 38518, 4, possessing mycosamine, and to Sch 38516, 7, containing 3,6-dideoxy-3-amino-Ltalopyranose. The chemical shifts for the sugar moiety agree with published data for mycosamine. The chemical shifts of mycosamine and 3,6-dideoxy-3-amino-L-talopyranose differ due to the inversion Table 1 -High resolution FABmass spectral data. of the hydroxyl group at C-4'. Thus in the 13C NMR spectra of compounds 1 to 4, we observed a 6~8ppm shift difference at C-3' compared to the C-3' shift in 7. The other carbon chemical shifts of the sugar portion are comparable. These data reflect that 1, 2, 3 and 4 all possess the same sugar, mycosamine. Wealso noted that the chemical shift Chemical shifts in S ppm relative to dioxane 67.6ppm in CDC13-CD3OD(1 : 1) solution. Assignments based on data obtained for 4 and 7 and on INEPT data for 1. indicated that differences occur due to the introduction of an extra methylene group at the substitution sites at C-5, C-9 or C-13. All other chemical shift assignments for 1~3 are in good agreement with those for both Sch 38518 and Sch 39185.
Biologial Properties
The in vitro antifungal activity of the various macrolactams is shown in Table 3 . For the homologous series of compounds containing mycosamine (Sch 38511, Sch 38512, Sch 38513 and Sch 38518), Sch 38518 was the most active compound against yeasts in both media. The decrease in antifungal activity observed for this series, corresponds to a decrease of the substitution around the macrolactam ring. For Sch 38518 and Sch 39185, which differ only in the sugar, comparable activity is observed.
Discussion
In this paper we have described the isolation of two series of novel macrolactams. The aglycone in these compounds has a 14 membered macrolactam having C-l or C-2 alkyl side chains at positions 5, 9 and 13. These compoundsform two homologous series containing mycosamineor 3,6-dideoxy-3-amino-L-talopyranoside. The antifungal potency increases for the higher homologs (Table 3 , see Sch 385 1 1 through Sch 38518). These compoundsrepresent a novel structural class which present a unique opportunity to prepare potent semi-synthetic analogs. Compounds4 and 8 have been recently reported as antivirals1243).
